The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The In Vitro Cancer Diagnostics Market During The Forecast Period 2026–2030?
The in vitro cancer diagnostics market size has shown significant growth in recent years. It is anticipated to expand from $11.49 billion in 2025 to $12.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be attributed to several factors including an increase in cancer prevalence, the widespread adoption of molecular diagnostics, the continuous development of immunoassay kits, the expansion of diagnostic laboratories, and ongoing advancements in reagent technologies.
The in vitro cancer diagnostics market size is anticipated to experience substantial growth in the upcoming years. It is forecast to expand to $16.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This expansion during the projection period can be attributed to advancements such as AI-enabled predictive analytics, the growth of personalized oncology, the development of high-throughput sequencing platforms, the increase in point-of-care diagnostics, and the adoption of cloud-based diagnostic software. Prominent trends for the forecast period include biomarker-based detection, the use of genetic profiling tools, the evolution of multiplex assay development, integration with laboratory information systems (lims), and the proliferation of rapid diagnostic kits.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29090&type=smp
What Drivers Are Expected To Influence The In Vitro Cancer Diagnostics Market During The Forecast Period?
The expanding uptake of liquid biopsy technologies is projected to drive the growth of the in vitro cancer diagnostics market moving forward. These technologies refer to minimally invasive diagnostic approaches that detect and analyze biomarkers, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or exosomes, found in bodily fluids like blood, urine, or saliva, for monitoring disease presence, progression, or response to treatment, particularly in cancer. Liquid biopsy technologies are evolving due to advancements in isolating and analyzing circulating tumor DNA and circulating tumor cells from blood and other body fluids. In vitro cancer diagnostic solutions are experiencing increased demand as the rapid expansion of liquid biopsy technologies encourages companies to adopt non-invasive and real-time molecular profiling tools for cancer detection and treatment guidance. For instance, in May 2025, according to NHS England, a UK-based public healthcare system, the new liquid biopsy blood test-first rollout in the UK is expected to benefit up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer annually, scaling rapidly from approximately 2,200 patients tested during the early 2025 rollout to a projected 20,000 patients per year by 2028. Therefore, the increasing adoption of liquid biopsy technologies is stimulating demand for the in vitro cancer diagnostics market.
What Market Segments Are Evaluated Within The In Vitro Cancer Diagnostics Market?
The in vitro cancer diagnostics market covered in this report is segmented –
1) By Product Type: Kits, Instruments, Reagents, Software, Consumables
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Other Technologies
3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Kits: Immunoassay Kits, Polymerase Chain Reaction (PCR) Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Flow Cytometry Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Instruments, Sequencers, Flow Cytometers, Imaging Systems
3) By Reagents: Enzymes, Buffers, Probes, Stains
4) By Software: Data Analysis Software, Imaging Software, Laboratory Information Management System (LIMS) Software, Diagnostic Reporting Software
5) By Consumables: Microplates, Pipette Tips, Tubes, Slides
What Industry Trends Are Redefining The In Vitro Cancer Diagnostics Market?
Leading companies in the in vitro cancer diagnostics market are concentrating on developing AI-powered cancer diagnostics to improve patient care and advance personalized healthcare. AI-driven cancer diagnostics utilizes artificial intelligence to analyze medical and molecular data from patient samples, imaging, or genetic tests, allowing for more accurate detection, diagnosis, and prediction of cancer. As an illustration, in September 2024, Roche, a Switzerland-based pharmaceutical company, introduced the Digital Pathology Open Environment, a collaborative platform that securely integrates advanced AI-based image analysis tools from Roche and various third-party developers. This platform provides pathologists access to innovative algorithms within Roche’s Navify Digital Pathology enterprise software, thereby enhancing diagnostic precision and improving workflow efficiency. By encouraging collaboration and data sharing, the platform accelerates innovation in cancer diagnostics and research, supports precision medicine, facilitates targeted treatments, and ultimately expands access to cutting-edge digital pathology tools globally.
Who Are The Top Market Participants Influencing The In Vitro Cancer Diagnostics Market?
Major companies operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics
Read the full in vitro cancer diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-cancer-diagnostics-global-market-report
Which Region Is Forecast To Lead The In Vitro Cancer Diagnostics Market In Terms Of Market Size?
North America was the largest region in the in vitro cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In Vitro Cancer Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29090&type=smp
Browse Through More Reports Similar to the Global In Vitro Cancer Diagnostics Market 2026, By The Business Research Company
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Bioinformatics In In Vitro Diagnostics Ivd Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model